Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of sickle cell disease, diabetic neuropathy, and cerebrovascular insufficiency.
説明 | Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of sickle cell disease, diabetic neuropathy, and cerebrovascular insufficiency. |
ターゲット&IC50 | A2B receptor:7 μM (Ki) |
別名 | Enprofilina, 3-propylxanthine, 3-n-Propylxanthine, Enprofyllinum |
分子量 | 194.19 |
分子式 | C8H10N4O2 |
CAS No. | 41078-02-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 60 mg/ml (308.98 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enprofylline 41078-02-8 Others Enprofilina chronic obstructive pulmonary interleukin-8 A2B receptor antagonist phosphodiesterase inhibitor Adenosine Receptor 3-propylxanthine Adenosine inhibit asthma Inhibitor phospholipase C P1 receptor Phosphodiesterase (PDE) 3-n-Propylxanthine Enprofyllinum inhibitor